Asterias Biotherapeutics, Inc. (NYSE MKT: AST) announced that it has completed the previously announced underwritten public offering and concurrent private placement of its common stock. The Company raised $5.5 million in aggregate gross proceeds from the public offering and the private placement, which it intends to use for the continued development of product candidates through clinical trials and for working capital and general corporate purposes.
On Tuesday shares of Asterias Biotherapeutics, Inc. (NYSEMKT:AST) closed at $3.85.
Pfenex Inc. (NYSE MKT: PFNX), and Hospira, Inc., (HSP), announced that the companies have entered into an agreement to exclusively develop and commercialize for worldwide sales PF582, Pfenex’s biosimilar candidate to Genentech’s LUCENTIS® (ranibizumab injection). Pfenex Inc. (NYSEMKT:PFNX) in last trading activity moved up 15.94% to close at $8.00. Company weekly performance is 18.52% while its quarterly performance stands at -4.08%. Pfenex Inc. (NYSEMKT:PFNX) is -11.11% away from its 52 week high.
CommScope Holding Company, Inc. (NASDAQ:COMM) releases its fourth quarter and full year 2014 financial results on Friday, February 20, 2015 before the market opens. On last trading day CommScope Holding Company, Inc. (NASDAQ:COMM) moved up 0.17% to close at $29.73. Its volatility for the week is 2.59% while volatility for the month is 4.36%. COMM’s sales growth for past 5 years was -2.80% and its EPS growth for past 5 years was 15.30%. CommScope Holding Company, Inc. (NASDAQ:COMM) monthly performance is 29.15%.
On 5 February, NICE Systems Ltd. (NASDAQ:NICE) announced Fourth quarter 2014 non-GAAP total revenues were a record $294.2 million, up 8.6% from $271.0 million for the fourth quarter of 2013. Non-GAAP total revenues for the full year 2014 increased 6.5% to $1,012.4 million compared to $951.0 million for the full year 2013. NICE Systems Ltd. (NASDAQ:NICE) has 5.17% insider ownership while its institutional ownership stands at 43.60%. In last trading activity company’s stock closed at $55.50.
Plains GP Holdings (NYSE:PAGP) had its price objective hosited by Stifel Nicolaus from $31.00 to $34.00 in a report released on Friday. Stifel Nicolaus currently has a buy rating on the stock. On last trading day Plains GP Holdings, L.P. (NYSE:PAGP) moved up 1.04% to close at $27.29. Its volatility for the week is 3.46% while volatility for the month is 3.93%. Plains GP Holdings, L.P. (NYSE:PAGP) monthly performance is 5.73%.